AdvaMed Commends White House on Relaunch of Cancer Moonshot
WASHINGTON, D.C. – In a letter to President Joe Biden today, AdvaMed President and CEO Scott Whitaker thanked the Administration for relaunching the Cancer Moonshot with an emphasis on cancer screening and advances in cancer testing, and he requested that the President include medtech industry leaders in an upcoming Cancer Moonshot Summit.
In the letter to President Biden, AdvaMed President and CEO Scott Whitaker wrote: “AdvaMed’s 450 member companies produce the medical devices, diagnostic tests, and health information systems that are transforming health care through earlier disease detection, less invasive procedures, and more effective treatments, particularly in terms of cancer care… Medical technology companies are innovators and partners with patients and clinicians, providing the screening, diagnostic tests, imaging, radiation therapy, surgical tools, and infusion pumps and medical supplies without which modern cancer care would not exist.
“Recognizing the critical role of medical technology in health care, we urge you to include medtech industry leaders as participants in a White House Cancer Moonshot Summit and future roundtable conversations on the issue.”
Read the full letter to President Biden here.
AdvaMed launched the Cancer Forum to bring together a wide range of medical technology companies whose products are the heart of precision medicine and essential components in every aspect of cancer prevention and care. The Cancer Forum advocates for effective regulation, modernized coverage and payment policies, and the investment in research that are all essential for expanding patient access to essential technologies, reducing health disparities, and supporting technology innovation and high-quality care for cancer patients.
# # #
AdvaMed member companies produce the medical devices, diagnostic products and digital health technologies that are transforming health care through earlier disease detection, less invasive procedures and more effective treatments. AdvaMed members range from the largest to the smallest medical technology innovators and companies. For more information, visit www.advamed.org.